Shares of Dr Reddy's Laboratories News
US-based law firm Lundin Law, which specialises in securities litigations is investigating claims against Dr Reddy's Laboratories for possible violations of federal security laws, which the drug maker has denied.
The stock has fallen by over 20 percent in three days.
Drug firm Dr Reddy's Laboratories has launched generic Paricalcitol capsules used for treating secondary hyperparathyroidism associated with chronic kidney disease in the American market, following approval by the US health regulator.
Loading...